Premium
IC‐P‐195: Patterns of in‐Vivo Preclinical TAU and Amyloid Burden Using [F‐18]THK5351 and [C‐11]PIB
Author(s) -
Johnson Sterling C.,
Betthauser Tobey J.,
Lao Patrick J.,
Murali Dhanabalan,
Barnhart Todd E.,
Stone Charles,
Asthana Sanjay,
Furumoto Shozo,
Okamura Nobuyuki,
Christian Bradley T.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.226
Subject(s) - pittsburgh compound b , dementia , medicine , cognitive decline , nuclear medicine , neuroimaging , alzheimer's disease , positron emission tomography , cognition , cognitive impairment , montreal cognitive assessment , pathology , neuroscience , psychology , disease , psychiatry
Sterling C. Johnson, Tobey J. Betthauser, Patrick J. Lao, Dhanabalan Murali, Todd E. Barnhart, Charles Stone, Sanjay Asthana, Shozo Furumoto, Nobuyuki Okamura, Bradley T. Christian, 1 Geriatric Research Education and Clinical Center, Wm. S. Middleton Veterans Hospital, Madison, WI, USA; 2 Wisconsin Alzheimer’s Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, WI, USA; 6 Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; CYRIC, Tohoku University, Sendai City, Japan; Tohoku University School of Medicine, Sendai city, Japan. Contact e-mail: scj@medicine.wisc.edu